Less is more: the impact of maintenance treatment adherence in severe asthma clinical trials

被引：5
作者：
McBrien, Claire N. [1 ]
Menzies-Gow, Andrew [2 ]
机构：
[1] Imperial Coll London, London, England
[2] Royal Brompton Hosp, Resp Med, Sydney St, London SW3 6NP, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 53卷 / 05期
关键词：
INHALED CORTICOSTEROIDS; MULTICENTER; THERAPY; BURDEN;
D O I：
10.1183/13993003.00599-2019
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Tralokinumab for the treatment of severe, uncontrolled asthma: the ATMOSPHERE clinical development program
    Panettieri, Reynold A., Jr.
    Wang, Millie
    Braddock, Martin
    Bowen, Karin
    Colice, Gene
    IMMUNOTHERAPY, 2018, 10 (06) : 473 - 490
  • [22] Clinical pharmacokinetics of magnesium sulfate in the treatment of children with severe acute asthma
    Rower, Joseph E.
    Liu, Xiaoxi
    Yu, Tian
    Mundorff, Michael
    Sherwin, Catherine M. T.
    Johnson, Michael D.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (03) : 325 - 331
  • [23] Comparison between clinical trials and real-world evidence studies on biologics for severe asthma
    Menzella, Francesco
    Ballarin, Andrea
    Sartor, Maria
    Floriani, Ariel Fabian
    Corsi, Lorenzo
    Dartora, Cristina
    Tonin, Silvia
    Romagnoli, Micaela
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (11)
  • [24] The clinical effectiveness of mepolizumab treatment in severe eosinophilic asthma; outcomes from four years cohort evaluation
    Reilly, Christopher
    Raja, Anandavelu
    Anilkumar, Pillai
    Sullivan, Julie
    White, Lisa
    Bahron, Ali
    Marsh, Julie
    Mansur, Adel H.
    JOURNAL OF ASTHMA, 2024, 61 (06) : 561 - 573
  • [25] Modelling ASthma TrEatment Responses (MASTER): Effect of individual patient characteristics on the risk of exacerbation in moderate or severe asthma: A time-to-event analysis of randomized clinical trials
    Oosterholt, Sean
    Pavord, Ian D. D.
    Brusselle, Guy
    Yorgancioglu, Arzu
    Pitrez, Paulo M. M.
    Pg, Abhijith
    Teli, Chirag
    Della Pasqua, Oscar
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (11) : 3273 - 3290
  • [26] Impact of treatment adherence and inhalation technique on asthma outcomes of pediatric patients: a longitudinal study
    Lizano-Barrantes, Catalina
    Garin, Olatz
    Mayoral, Karina
    Dima, Alexandra L.
    Pont, Angels
    Caballero-Rabasco, Maria Araceli
    Praena-Crespo, Manuel
    Valdesoiro-Navarrete, Laura
    Guerra, Maria Teresa
    Bercedo-Sanz, Alberto
    Ferrer, Montse
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] Evaluation of diagnostic criteria for severe asthma described in a public health directive regulating the free distribution of medications for the maintenance treatment of asthma
    Carvalho da Silva Santos, Maria Amelia
    Godoy Fernandes, Ana Luisa
    Amorim, Mara Marta
    Lima, Patricia Bueno
    Faresin, Sonia Maria
    Santoro, Ilka Lopes
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2009, 35 (04) : 310 - 317
  • [28] Rationale and Clinical Results of Inhibiting Interleukin-5 for the Treatment of Severe Asthma
    Berair, Rachid
    Pavord, Ian D.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2013, 13 (05) : 469 - 476
  • [29] Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials
    van Dijkman, Sven C.
    Yorgancioglu, Arzu
    Pavord, Ian
    Brusselle, Guy
    Pitrez, Paulo M.
    Oosterholt, Sean
    Fumali, Sourabh
    Majumdar, Anurita
    Della Pasqua, Oscar
    ADVANCES IN THERAPY, 2024, 41 (03) : 1201 - 1225
  • [30] Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials
    Sven C. van Dijkman
    Arzu Yorgancıoğlu
    Ian Pavord
    Guy Brusselle
    Paulo M. Pitrez
    Sean Oosterholt
    Sourabh Fumali
    Anurita Majumdar
    Oscar Della Pasqua
    Advances in Therapy, 2024, 41 : 1201 - 1225
12345